EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment outcomes and associated factors among patients with rifampicin-resistant tuberculosis in Guangxi, 2020–2023

Chongxing Zhou, Jing Ye, Zhezhe Cui, Yan Huang, Qingpeng Yang, Minying Huang, Liwen Huang, Huifang Qin, Jianfeng Ou

Frontiers in Public Health · 16.11.2026 · 14

DOI: 10.3389/fpubh.2026.1983542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 16.11.2026. Verfasst von Chongxing Zhou und 8 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rifampicin-resistant tuberculosis is a major challenge to tuberculosis control in Guangxi, China. This study aims to investigate the treatment status and influencing factors of rifampicin-resistant tuberculosis in the region from 2020 to 2023, and to provide evidence for precise prevention and control strategies.

Methods

Case information of tuberculosis patients in Guangxi was collected from the Tuberculosis Information Management System (a subsystem of the China Information System for Disease Control and Prevention). Treatment characteristics were described, chi-square test was used to analyze drug-resistant treatment status, and univariate and multivariate Logistic regression analyses were conducted to identify factors influencing treatment outcomes.

Results

A total of 1827 rifampicin-resistant tuberculosis patients were identified, and 1713 started treatment,with an overall treatment enrollment rate of 93.76% (trend χ 2 = 33.072, p < 0.05) showing a decreasing trend. Among the 1713 patients who initiated treatment, the treatment success proportion was 50.55% (866/1713). Males accounted for 79.97% of cases, and both genders had declining enrollment rates ( p < 0.05). The 40–59 age group made up 43.51%, and enrollment rates decreased in 20–39, 40–59, and ≥60 age groups (all p < 0.05). Enrollment rates across 14 cities ranged from 54.05% to 100%, with Liuzhou, Guigang, Hechi, and Laibin showing declines (all p < 0.05). Multivariate analysis identified male gender (OR = 1.48,95% CI:1.14–1.92), age≥60 years (OR = 4.11,95%CI:1.57–10.76), Zhuang ethnicity (OR = 1.75, 95% CI:1.4–2.18), other ethnicities (OR = 2.28,95% CI:1.33–3.92) and retreatment (OR = 1.57, 95% CI:1.28–1.92), as risk factors for unfavorable treatment outcome.

Conclusion

Guangxi’s rifampicin-resistant tuberculosis treatment enrollment rate is relatively high but declining. Strengthened efforts are needed to reverse this trend, Optimizing patient referral pathways, rationally distributing health resources and delivering targeted health education for high-risk groups are recommended to strengthen local RR-TB prevention and control.

Zitieren

APA

Zhou, C., Ye, J., Cui, Z., Huang, Y., Yang, Q., Huang, M., Huang, L., Qin, H., & Ou, J. (2026). Treatment outcomes and associated factors among patients with rifampicin-resistant tuberculosis in Guangxi, 2020–2023. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1983542

Vancouver

Zhou C, Ye J, Cui Z, Huang Y, Yang Q, Huang M, et al. Treatment outcomes and associated factors among patients with rifampicin-resistant tuberculosis in Guangxi, 2020–2023. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1983542

BibTeX
@article{Zhou2026,
  author = {Zhou, Chongxing and Ye, Jing and Cui, Zhezhe and Huang, Yan and Yang, Qingpeng and Huang, Minying and Huang, Liwen and Qin, Huifang and Ou, Jianfeng},
  title = {Treatment outcomes and associated factors among patients with rifampicin-resistant tuberculosis in Guangxi, 2020–2023},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1983542}
}
Kostenlos starten →